impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5

1, 2, 3, 4, 5, 6

 

  1. Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  2. Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  3. Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  4. Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  5. Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  6. Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. zhangzhiyi03@126.com

CER12566
2020 Vol.38, N°4
PI 0713, PF 0723
Full Papers

purchase article

PMID: 31694750 [PubMed]

Received: 04/07/2019
Accepted : 02/09/2019
In Press: 30/10/2019
Published: 28/07/2020

Abstract

OBJECTIVES:
Rheumatoid arthritis (RA) is a systematic autoimmune disease that cardinally affects the joints and other organs. Many people all over the world are suffering from the disease and no effective treatment has been established. Fibroblast-like synoviocytes (FLSs) play a critical role in the occurrence and development of RA. Long non-coding RNA Fer-1-like protein 4 (FER1L4) has been reported to participate in various cancers as a tumour suppressor. However, its clinical significance and biological role in RA is completely unknown.
METHODS:
RT-qPCR or FISH were used to examine the expression of FER1L4 NLRC5, FER1L4 and inflammatory cytokine levels in synovial tissues (STs) from patients with RA or RA FLSs. Western blot was applied to examine the expression of NLRC5 and inflammatory cytokine levels in synovial tissues (STs) from patients with RA or RA FLSs. BrdU staining and MTT assay were used to examine the cell proliferation ability. The methylation-specific PCR was performed to analyse the methylation levels.
RESULTS:
The level of FER1L4 significantly reduced in STs and FLSs, whereas the nucleotide oligomerisation domain-like receptors 5 (NLRC5) levels were increased. Overexpression of FER1L4 can decreased the level of NLRC5 and inflammatory cytokine level. The FER1L4 gene promoter was significantly methylated in RA STs and FLSs. More importantly, treatment with methylation inhibitor 5-aza-2-deoxycytidine (5-azadC) inhibited hypermethylation of FER1L4 promoter and the expression of NLRC5.
CONCLUSIONS:
These results indicated that FER1L4 regulates RA via targeting NLRC5 potentially. Therefore, this study may provide a candidate therapeutic target for RA.

Rheumatology Article